Scavenger receptors target glycolipids for natural killer T cell activation

Journal of Clinical Investigation

Volumn 122, Issue 11, 2012, Pages 3943-3954

  Freigang, Stefan ^a,e   Landais, Elise ^a   Zadorozhny, Victoria ^a   Kain, Lisa ^a   Yoshida, Kenji ^a   Liu, Yang ^b   Deng, Shenglou ^b   Palinski, Wulf ^c   Savage, Paul B ^b   Bendelac, Albert ^d   Teyton, Luc ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Brigham Young University   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 2; INTERLEUKIN 4; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYBRIDOMA; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; SPHINGOMONAS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD1D; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; GALACTOSYLCERAMIDES; GLYCOSPHINGOLIPIDS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; RECEPTORS, SCAVENGER; SPHINGOMONAS;

EID: 84868628556     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62267     Document Type: Article

References (51)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801. (Pubitemid 43261452)
2. Beutler B, et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol. 2006;24:353-389.
3. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819-826. (Pubitemid 47598622)
4. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637-650.
5. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426. (Pubitemid 47509552)
6. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817-890. (Pubitemid 38680443)
7. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;23:877-900. (Pubitemid 40563188)
8. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25:297-336. (Pubitemid 46697911)
9. Coquet JM, et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17- producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A. 2008;105(32):11287-11292.
10. Fujii S, Shimizu K, Hemmi H, Steinman RM. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol Rev. 2007;220:183-198. (Pubitemid 350045564)
11. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med. 2003;198(2):267-279. (Pubitemid 36987852)
12. Hermans IF, et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol. 2003;171(10):5140-5147. (Pubitemid 37432797)
13. Galli G, et al. Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci U S A. 2007;104(10):3984-3989. (Pubitemid 47181565)
14. Cui J, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278(5343):1623-1626. (Pubitemid 27516281)
15. Smyth MJ, et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med. 2000;191(4):661-668.
16. Cerundolo V, Silk JD, Masri SH, Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol. 2009;9(1):28-38.
17. Fujii S, Motohashi S, Shimizu K, Nakayama T, Yoshiga Y, Taniguchi M. Adjuvant activity mediated by iNKT cells. Semin Immunol. 2010;22(2):97-102.
18. van den Elzen P, et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature. 2005;437(7060):906-910.
19. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111(7):927-930. (Pubitemid 36044685)
20. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem. 1983;52:223-261. (Pubitemid 13030685)
21. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 1990;343(6258):531-535.
22. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268(16):11811-11816. (Pubitemid 23168135)
23. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997;8(5):275-280. (Pubitemid 27462434)
24. Areschoug T, Gordon S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol. 2009;11(8):1160-1169.
25. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature. 1991;352(6333):342-344. (Pubitemid 21912355)
26. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A. 1994;91(5):1863-1867. (Pubitemid 24080306)
27. Zhu FG, Reich CF, Pisetsky DS. The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Immunology. 2001;103(2):226-234. (Pubitemid 32521352)
28. Hoebe K, et al. CD36 is a sensor of diacylglycerides. Nature. 2005;433(7025):523-527. (Pubitemid 40204309)
29. Stewart CR, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010;11(2):155-161.
30. Suzuki H, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386(6622):292-296. (Pubitemid 27142516)
31. Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, El Khoury J. Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med. 2000;191(1):147-156.
32. Arredouani MS, Yang Z, Imrich A, Ning Y, Qin G, Kobzik L. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol. 2006;35(4):474-478. (Pubitemid 44477647)
33. Abraham R, Singh N, Mukhopadhyay A, Basu SK, Bal V, Rath S. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J Immunol. 1995;154(1):1-8.
34. Berwin B, et al. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 2003;22(22):6127-6136. (Pubitemid 37463255)
35. Prigozy TI, et al. Glycolipid antigen processing for presentation by CD1d molecules. Science. 2001;291(5504):664-667. (Pubitemid 32150427)
36. Kinjo Y, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 2005;434(7032):520-525. (Pubitemid 40477061)
37. Mattner J, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 2005;434(7032):525-529. (Pubitemid 40477062)
38. Liu Y, et al. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol. Methods. 2006;312(1-2):34-39. (Pubitemid 43795980)
39. Gadola SD, et al. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med. 2006;203(10):2293-2303. (Pubitemid 44498364)
40. Freigang S, et al. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J Clin Invest. 2010;120(6):1873-1884.
41. Zhou D, et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science. 2004;303(5657):523-527. (Pubitemid 38120850)
42. Schrantz N, Sagiv Y, Liu Y, Savage PB, Bendelac A, Teyton L. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J Exp Med. 2007;204(4):841-852. (Pubitemid 46631613)
43. Moody DB, et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol. 2002;3(5):435-442. (Pubitemid 34520792)
44. Bendelac A, Teyton L, Savage PB. Lipid presentation by CD1: the short and the long lipid story. Nat Immunol. 2002;3(5):421-422. (Pubitemid 34520789)
45. Bai L, et al. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc Natl Acad Sci U S A. 2009;106(25):10254-10259.
46. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol. 2003;170(5):2302-2309. (Pubitemid 36245615)
47. Freigang S, Horkko S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol. 1998;18(12):1972-1982. (Pubitemid 28565762)
48. Braun NA, Covarrubias R, Major AS. Natural killer T cells and atherosclerosis: form and function meet pathogenesis. J Innate Immun. 2010;2(4):316-324.
49. Fox LM, et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 2009;7(10):e1000228.
50. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1983;92(2):883-893.
51. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997;94(23):12610-12615. (Pubitemid 27492576)